Alphamab Oncology’s JSKN033 Gets Green Light for Phase I/II Study from China’s CDE
China-based Alphamab Oncology (HKG: 9966) has announced that it has received approval from the Center...
Drug
CSPC Pharmaceutical’s SYH2062 Receives NMPA Clearance for Hypertension Treatment
China-based CSPC Pharmaceutical Group Co., Ltd. (HKG: 1093) has announced that it has received clinical...
Keymed Biosciences’ Kangyueda Approved for CRSwNP Treatment in China
China-based Keymed Biosciences Inc., (HKG: 2162) has announced that it has received another indication approval...
Sichuan Biokin’s GNC-038 Tetra-Specific Antibody Clears for Clinical Trials in Autoimmune Diseases
Sichuan Biokin Pharmaceutical Co., Ltd (SHA: 688506), a China-based pharmaceutical company, has announced that it...
Changchun High & New Technology Industries Receives FDA Approval for Menopausal VMS Drug Trial
China-based Changchun High & New Technology Industries (Group) Inc., (SHE: 000661) has received the green...
AstraZeneca’s Tagrisso Secures EU Approval for EGFR-Mutated Locally Advanced NSCLC
UK pharmaceutical major AstraZeneca (AZ, NASDAQ: AZN) has announced that the European Commission (EU) has...
ETERN Therapeutics’ YAP/TEAD Inhibitor ETS-006 Wins FDA Clinical Approval for Advanced Solid Tumors
China-based biopharmaceutical company ETERN Therapeutics has announced that it has received clinical approval from the...
Bristol-Myers Squibb’s Opdivo-Yervoy Combo Approved by EC for MSI-H/mCRC
Global biopharmaceutical company Bristol-Myers Squibb (BMS, NYSE: BMY) has announced that it has received marketing...
Roche’s Lunsumio Receives NMPA Approval for R/R Follicular Lymphoma Treatment
Swiss pharmaceutical giant Roche (SWX: ROG) has announced that it has received marketing approval from...
GSK’s Jemperli Combo Shows Improved PFS in Phase III Ovarian Cancer Trial
UK-based GSK plc (NYSE: GSK) has announced a positive readout from the Phase III FIRST-ENGOT-OV44...
Pfizer’s Braftovi Receives FDA Approval for Metastatic Colorectal Cancer Treatment
US-based Pfizer (NYSE: PFE) has announced receiving an indication extension approval from the US Food...
Eli Lilly’s Zepbound Receives FDA Approval for Moderate-to-Severe OSA and Obesity
US pharmaceutical giant Eli Lilly & Co. (NYSE: LLY) has revealed that the US Food...
Novo Nordisk’s Alhemo Receives FDA Approval for Hemophilia A and B Prophylaxis
Denmark-based Novo Nordisk A/S (NYSE: NVO) has announced that the US Food and Drug Administration...
CStone Pharmaceuticals Initiates First-in-Human Trial for PD-1/VEGF/CTLA-4 Trispecific Antibody CS2009
China-based CStone Pharmaceuticals (HKG: 2616) has announced the clinical filing for its CS2009, a PD-1/VEGF/CTLA-4...
Yifan Pharmaceutical’s Evive Biotech Receives ANVISA Approval for Ryzneuta
China-based Yifan Pharmaceutical Co., Ltd (SHE: 002019) has announced that its subsidiary, Evive Biotech Ltd,...
Changchun BCHT Biotechnology Receives NMPA Approval for HSV-2 mRNA Vaccine LVRNA101
Changchun BCHT Biotechnology Co., Ltd (SHA: 688276), a China-based biotechnology company, has announced receiving clinical...
Shenzhen Chipscreen Biosciences Gets NMPA Approval for CS231295 Solid Tumor Study
Shenzhen Chipscreen Biosciences Co., Ltd (SHA: 688321), a China-based biopharmaceutical company, has announced receiving the...
Jiangsu Hengrui Pharmaceuticals Gets NMPA Approval to Test SHR-1681 in Clinical Trials
Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SHA: 600276) has announced that it has received approval from...
CSPC Pharmaceutical’s SYH9017 Receives NMPA Clearance for Weight Management Clinical Trial
China-based CSPC Pharmaceutical Group Co., Ltd. (HKG: 1093) has announced clinical clearance from the National...
CSPC Pharmaceutical Group Receives NMPA Approval for Two Antibody-Drug Conjugates
China-based CSPC Pharmaceutical Group Co., Ltd. (HKG: 1093) has announced that it has received separate...